Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
about
Interventions for reduction of stigma in people with HIV/AIDSBehavioral characteristics of seroconverted intravenous drug users.Changes in HIV risk behaviors among intravenous drug users in San Juan, Puerto Rico.Effect of psychological factors on risk behavior of human immunodeficiency virus (HIV) infection among intravenous drug users (IVDUs).Improving Condom Self-Efficacy and Use among Individuals Living with HIV: The Positive Choices Mapping Intervention.Acceptability of a safer injection facility among injection drug users in San Francisco.Longitudinal analysis of the relationship between perceived norms and sharing injection paraphernalia.AIDS and intravenous drug use: the real heterosexual epidemic.HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.Drug abuse treatment as AIDS prevention.Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.Correlates of participation in AIDS education and HIV antibody testing by methadone patientsDrug users' AIDS-related knowledge, attitudes, and behaviors before and after AIDS education sessionsFollowup study of possible HIV seropositivity among abusers of parenteral drugs in 1971-72.Drug use and sexual behavior of indigent African American men.Reliability and construct validity of the needle sharing inventory.AIDS in New York City: the role of intravenous drug users.HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.Drug injecting and HIV infection: new directions for social science research.Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.The first and second decades of AIDS among injecting drug users.Social intervention against AIDS among injecting drug users.Assessing AIDS prevention for injecting drug users; some methodological considerations.Mental disorders and drug abuse in persons living with HIV/AIDS.Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998The role of sexual transmission of HIV infection among injection and non-injection drug usersTrends in the AIDS epidemic among New York City's injection drug users: localized or citywide?Characteristics of drug abusers that discriminate needle-sharers.Gender differences in social network influence among injection drug users: perceived norms and needle sharing.Research on needle exchange: redefining the agenda.Psychosocial predictors of needle sharing among intravenous drug users.Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU)Barriers to practicing risk reduction strategies among people who inject drugs.Worry as a window into the lives of people who use injection drugs: a factor analysis approach.HIV among drug injectors: the epidemic and the response.Some lessons learned about risk reduction after ten years of the HIV/AIDS epidemic.Severity of heroin dependence and HIV risk. II. Sharing injecting equipment.Knowledge about and behaviors affecting the spread of AIDS: a street survey of intravenous drug users and their associates in New York City.From ideology to logistics: the organizational aspects of syringe exchange in a period of institutional consolidation.AIDS education in the schools: a literature review as a guide for curriculum planning.
P2860
Q24244508-F4F1A150-65FD-449C-8259-0E26A23715F4Q31005289-75A188EE-C012-4E88-9EB5-C773AAEB406CQ33215788-CD3E9FED-6612-431A-970F-2A643D1B66F4Q33432416-892A9F79-0180-411B-BB34-F60BAAC9773AQ33786623-BB4B584B-1614-45BC-953B-CB0420982AB6Q33912772-B1C683C6-C721-4B89-AE9B-3DB54EE997C3Q33937505-BB4A7D64-FBE9-49D6-87AD-52D549034F91Q34068601-5194AEED-56F1-4D64-9741-950FB76D4A75Q34163291-25CB1E87-524F-4415-B499-E82B6E25E6A8Q34196421-6D03F3A9-2C1C-4DD7-9998-24CB336EC5DBQ34389303-6CC89DDC-6047-4F77-B4AC-DD16B03CA567Q35054302-369442F2-6B14-43DB-980A-84B065FF24DFQ35054919-B1B54C7A-17F7-4BED-9054-4B1DACD2AEB7Q35055405-A3363558-92F8-437E-A2B7-66CCF6F4074DQ35055495-465EEA18-FB9D-4C89-887F-F97BCBA6CBD4Q35638166-8E7A14A0-D359-4795-88B5-2F562715875FQ35657805-5B886245-C0E8-4EAA-86D9-8719F87C3CAEQ35659939-39C59EC4-45AB-44E7-B073-19CBC8A1A5D4Q35901442-5B231EA8-40C6-4240-9997-1F2680CF1BF7Q35933574-708C7A9A-E6A1-4DE3-AAF1-C94C510FBC6FQ35979838-5E0DE0BD-B8EE-42DD-9BB0-AC50462D35D4Q35979883-4A3DABDC-09D2-448F-86FB-9114134F38D4Q35979974-E47B13CB-C2C4-4915-9538-F709E1C34F9FQ36057255-F904B1AD-1FD1-4099-B2D3-913B28964A16Q36272696-A516320B-F21E-47BB-A181-F246A0A9E76FQ36273534-4AFE744C-5FA5-4CF8-912F-77FF69DB20AFQ36273958-983190F9-D42F-4715-A854-EA0BC3263ED2Q36432114-ADA95052-DCB3-4B76-ABED-DE4676FADAC4Q36441013-F3936FAB-B4C1-4F2C-A8C6-CD22107A907EQ36608032-682D4112-B3F3-451A-A8F1-F5B5405858AEQ36773616-2A599F6D-9880-4ED5-80EC-CF54AC41BF62Q36989554-89B6FEC0-68F4-406A-AE1B-D86F37D1F019Q37149214-8CE2C43F-093C-4A85-AD85-F08F8339484AQ37299200-ABF71A00-18E4-49ED-A9E5-61CCC1FB4F96Q37423621-B4E15DB7-1E68-4AB2-A0BA-BDD8AC4417FFQ37423626-0B8EDA37-9DC1-42B9-BDE8-60BF460DEDBFQ38566475-A478E233-C256-46B6-811A-A4DD6CF2C4BFQ39263341-0473EA82-3D55-45A8-A8B3-3154CE6089B1Q39467648-11823C0D-0741-4C52-B832-618218AA8355Q39651048-7065033C-570E-488C-BD71-4F70F664E844
P2860
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
@en
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
@nl
type
label
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
@en
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
@nl
prefLabel
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
@en
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
@nl
P2093
P1476
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
@en
P2093
Des Jarlais DC
Friedman SR
P304
P356
10.7326/0003-4819-103-5-755
P407
P577
1985-11-01T00:00:00Z